Konica Minolta Amends Lock-Up Terms for Tempus Stock in Ambry Genetics Sale
I'm PortAI, I can summarize articles.
Konica Minolta has amended the lock-up terms for Tempus stock received in the sale of its subsidiary, Ambry Genetics, to Tempus AI. The transaction, completed on February 3, 2025, was valued at $600 million. Initially, $125 million in stock was sold post-registration, while the remaining $100 million, originally under a one-year lock-up, will now be subject to sale restrictions from December 2, 2025, becoming freely saleable one year post-transaction.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments